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RPGR-interacting protein 1 (RPGRIP1) is mutated
in the eye disease Leber congenital amaurosis
(LCA) and its structural homolog, RPGRIP1-like
(RPGRIP1L), is mutated in many different ciliopa-
thies. Both are multidomain proteins that are pre-
dicted to interact with retinitis pigmentosa G-protein
regulator (RPGR). RPGR is mutated in X-linked reti-
nitis pigmentosa and is located in photoreceptors
and primary cilia. We solved the crystal structure of
the complex between the RPGR-interacting domain
(RID) of RPGRIP1 and RPGR and demonstrate that
RPGRIP1L binds to RPGR similarly. RPGRIP1 bind-
ing to RPGR affects the interaction with PDEd, the
cargo shuttling factor for prenylated ciliary proteins.
RPGRIP1-RID is a C2 domain with a canonical b
sandwich structure that does not bind Ca2+ and/or
phospholipids and thus constitutes a unique type
of protein-protein interaction module. Judging from
the large number of C2 domains in most of the ciliary
transition zone proteins identified thus far, the struc-
ture presented here seems to constitute a cilia-spe-
cific module that is present in multiprotein transition
zone complexes.INTRODUCTION
Cilia are microtubule-based organelles that project from the sur-
face of most eukaryotic cells. Motile cilia usually have a 9 + 2
microtubule doublet structure and control fluid or particle flows
over epithelial surfaces (e.g., in the airways and the fallopian
tube). Primary cilia generally lack the central microtubule doublet
and consist of a 9 + 0 structure. They partake in several signal
transduction pathways, such as the Sonic Hedgehog and Wnt
pathways, and play a role in chemosensation, mechanosen-
sation, and thermosensation. Ciliary defects lead to pleiotropic
disorders, often characterized by photoreceptor degradation,
kidney cysts, altered embryonic patterning, and mental retarda-
tion. These diseases are now commonly referred to as ciliopa-
thies (Fliegauf et al., 2007; Gerdes et al., 2009).
The ciliary axoneme grows out of the basal body and is
covered by the ciliary membrane. The region most proximalto the basal body is called the transition zone and is thought
to act as gatekeeper structure that controls the entry and exit
of proteins into and out of the cilium. Transition fibers linking
the outer doublets to the membrane and the Y-linkers in the
transition zone form a physical barrier that limits the free diffu-
sion of soluble proteins into the cilium. Active or facilitated
transport processes probably are particularly relevant for trans-
membrane proteins, as several ciliary targeting sequences
(CTSs) have been identified (e.g., in rhodopsin) (Deretic et al.,
1998).
The outer segment of photoreceptors represents a highly
specialized form of a primary cilium and is responsible for photo-
transduction. Since the cell’s metabolic machinery is present in
the inner segment, the proteins required for light sensing and
outer-segment maintenance are trafficked from the inner to the
outer segment via the connecting cilium, which is equivalent to
the transition zone in other primary cilia. Retinal degeneration
as a consequence of cilia malfunction occurs in many ciliopa-
thies, and mutations in a large number of genes are responsible
for retinal degeneration.
Two proteins encoded by such genes are retinitis pigmen-
tosa G-protein regulator (RPGR) and its molecular partner,
RPGR-interacting protein 1 (RPGRIP1). Defects in the RPGR
gene are a major cause of X-linked retinitis pigmentosa (RP),
wheras defects in RPGRIP1 lead to the more severe Leber
congenital amaurosis (LCA) syndrome (Dryja et al., 2001;
Meindl et al., 1996). LCA is characterized by retinal dystrophy
from birth or early childhood. Recently, RPGRIP1 has also
been implicated in various forms of glaucoma (Ferna´ndez-Mar-
tı´nez et al., 2011). RPGR has two major isoforms: RPGR1-19
and RPGRORF15. RPGR1-19 is produced from exon 1-19 of
the X-linked retinitis pigmentosa 3 gene, whereas RPGRORF15
contains exon 1-14 supplemented with the purine-rich intron
15 (Meindl et al., 1996; Vervoort et al., 2000). Hence, both
proteins contain the same N terminus, but differ in their C ter-
minus. The N terminus comprises a domain homologous to
regulator of chromosome condensation 1 (RCC1), an exchange
factor for the small G protein Ran. This RCC1 domain interacts
with several proteins, such as RPGRIP1 and the phosphodies-
terase 6 delta subunit (PDEd) (Boylan and Wright, 2000; Linari
et al., 1999). RPGRIP1 is a large multidomain protein con-
sisting of an N-terminal coiled coil domain, two C2 domains
(C2N and C2C), and a C-terminal RPGR-interacting domain
(RID). A homolog of RPGRIP1 called the RPGRIP1-like
(RPGRIP1L) protein (also called NPHP8), which possesses
the same domain architecture, has been identified as well.Cell Reports 8, 1–9, July 10, 2014 ª2014 The Authors 1
Figure 1. Domain Architecture of the RPGRIP1 and RPGRIP1L
Proteins and Activity of the RPGRIP1-RID Constructs
(A) Schematic representation of the domain architecture of RPGRIP1 and
RPGRIP1L. The starting points of the different RID and RIDL constructs are
shown in the insets. The LCA mutation found in the RID is indicated in red.
(B) Pull-downs of Strep-tagged RPGR and RID proteins of different sizes. The
RID construct that was added to RPGR is indicated above each lane (the name
refers to the number of residues). As a positive control, only RPGR was added
to the Streptactin beads. To check for unspecific binding, RID222 was added
to the Streptactin beads as a negative control.Several mutations have been detected in the RPGR RCC1
domain in RP patients. In RPGRIP1 and RPGRIP1L, patient
mutations are present in the coiled coils, the C2 domains,
and the RID. Both RPGRIP1 and RPGRIP1L interact with the
ciliary transition zone protein nephrocystin 4 (NPHP4) via their
C2C domain, and some of the patient mutations have been
shown to disrupt this interaction (Arts et al., 2007; Roepman
et al., 2005).
The expression of RPGRIP1 seems to be limited to the retina,
where it is expressed in photoreceptors, in the inner retina, and in
amacrine cells (Castagnet et al., 2003; Mavlyutov et al., 2002).
RPGR1-19 and RPGRIP1L are found in other tissues as well,
such as the brain and kidney (Arts et al., 2007; Hong et al.,
2000). RPGR and RPGRIP1 colocalize in the outer segments
of human and bovine photoreceptors (Mavlyutov et al., 2002).
In mice, however, they have been found to colocalize in the con-
necting cilium. RPGRIP1/ mice display a more severe pheno-
type than RPGR/ mice, which resembles the differences in
severity of human RP and LCA. Loss of RPGRIP1 also leads
to defects in disc formation in the photoreceptor outer segment,
suggesting an additional role for RPGRIP1 in disc morphogen-
esis (Zhao et al., 2003).
To obtain more insight into the interaction between RPGR and
RPGRIP1, in the present paper we structurally and biochemically
analyze the complex between the RCC1 domain of RPGR and
the RID of RPGRIP1 and RPGRIP1L.2 Cell Reports 8, 1–9, July 10, 2014 ª2014 The AuthorsRESULTS
Structure Solution
The C-terminal domain of RPGRIP1 was previously described as
an interaction partner of the RCC1 domain of RPGR. Since the
exact boundaries of the RID of RPGRIP1 were not known, we
created several constructs (Figure 1A). For the RCC1 domain
of RPGR, we chose to work with a construct comprising amino
acids 1–392 plus a C-terminal StrepII tag (hereafter referred to
as RPGR).
To find the best polypeptide for the RID of RPGRIP1, we pro-
duced six constructs starting from amino acids S1047, S1065,
S1084, S1091, I1102, and D1114, respectively, and ending
with the C-terminal residue S1286, producing proteins of 240,
222, 203, 196, 185, and 173 residues. We refer to these proteins
as RID240, RID222, RID203, RID196, RID185, and RID173,
respectively. Pull-downs with Strep-tagged RPGR show that
the RID constructs starting from amino acid S1047, S1065,
S1084, and S1091 bind to RPGR, whereas the smaller ones
starting from residues I1102 and D1114 do not (Figure 1B). To
gain more insights into this interaction, we solved the crystal
structure of the RPGR-RID196 complex. The best crystals dif-
fracted to 1.83 A˚ and allowed us to solve the crystal structure
by combining the phases obtained from a SeMet derivative of
RID196 and a molecular replacement template of RPGR (Table
S1). The asymmetric unit contained one copy of each molecule.
Residues 7–368 of RPGR and residues 1114–1281 of RID196
were clearly visible. An unconnected, strong difference in elec-
tron density was observed at the side of the RPGR b propeller
and could be unambiguously assigned to residues D1097–
M1106 of the RID196 N terminus because of the anomalous
signal of the residue M1106.
The Components
As described previously (Wa¨tzlich et al., 2013), RPGR forms a
seven-bladed b propeller. The root-mean-square deviation
(rmsd; for Ca) between the crystal structures of RPGR alone
(Protein Data Bank [PDB] ID 4JHN, chain A) and in complex
with RID196 is 0.42 A˚. The positions of the b sheets do not differ
significantly, but there are some small variations in the connect-
ing loop regions. The largest change is found in the long loop
connecting blade 1 and blade 7 of the propeller, which forms
part of the RPGR-RPGRIP1 interface. The rmsd (for Ca) between
the structures of RPGR in complex with RID196 and in complex
with PDEd (PDB ID 4JHP) is 0.56 A˚ and shows similar differences
in the loop between blades 1 and 7.
RPGRIP1 contains two sequences that have been recognized
as C2 domains, designated C2N andC2C (Figure 1A). The fold of
the RID was unknown, although one paper suggested it might be
a C2 domain as well (Zhang and Aravind, 2012). The structure
shows that the RID of RPGRIP1 displays a proper C2 domain
fold (Figure S1A). It consists of an eight-stranded antiparallel b
sandwich. Based on the topology of the b strands, C2 domains
are classified as either type I or type II. The type II topology dis-
plays a circular permutation of the order of the b strands found in
type I C2 domains. These topologies were originally described
in synaptotagmin C2A (type I) and in the C2 domain of PLCd1
(type II) (Essen et al., 1996; Sutton et al., 1995). As shown in
Figure 2. Analysis of the RPGR-RPGRIP1 Interaction
(A and B) Orientation (A) and close-up view (B) of the contact area 1 interface of
the RPGR-RID196 complex.
(C and D)Orientation (C) and close-up view (D) of the contact area 2 interface of
the RPGR-RID196 complex.
(E) Close-up view of the interface formed between RPGR and the N terminus of
RID196.
(F and G) Schematic overview of the interactions between the RPGR and
RID196 residues in (F) contact area 1 and (G) contact area 2. Salt bridges are
indicated by black lines, H bonds are shown as black dotted lines, and hy-
drophobic interactions are shown as gray dotted lines. The stacked interaction
between H1174 and R323 is shown in red.Figure S1B, RID196 exhibits a type II topology. Sheet 1 of the b
sandwich comprises b strands 1, 4, 7, and 8. Sheet 2 consists of
b2, b3, b5, and b6, although the b3 strand is remarkably shorter
than the other b strands. A small a-helical turn is localized
in the loop between b1 and b2. At the tip of the molecule where
the N and C termini converge, three a helices are present in the
loops connecting b4 and b5 (a2), b6 and b7 (a3), and C-terminal
to b8 (a4).
The RPGR-RID196 Complex
In the crystal structure, two different interaction surfaces of
RPGR and RID196 are found between symmetry-related mole-cules (Figure 2). Given that gel-filtration analysis shows that
the two proteins form an equimolar complex (Figure S1C), we
decided to use mutagenesis to identify the correct interface.
In contact area 1, the loop connecting b strands 4 and 5 of
RID196 touches the top of the RPGR b propeller (Figures 2A
and 2B). Hydrogen bonds (H bonds) and salt bridges that formed
between residues of RID196 and RPGR in this orientation are
shown schematically in Figure 2F. This interface buries 878 A2.
The second interface (area 2) involves an interaction between
RPGR and RID196, which buries 1,401 A2 of surface (Figures
2C–2E). Furthermore, in this orientation the small N-terminal
peptide of the same RID196 molecule can contact the side of
the RPGR b propeller (Figure 2E) and supplies an additional sur-
face area of 1161 A2. The latter interactions between the proteins
are depicted in Figure 2G.
To assess which of these two orientations reflects the real
interaction, we tested a number of mutant RID proteins in pull-
downs. Since the slightly longer construct RID222 performs bet-
ter in pull-downs than RID196, we chose to use this construct
in all biochemical experiments. In the area 1 mutant, residues
K1147, K1220, K1221, and E1222 were simultaneously replaced
by alanines. In the area 2 mutant, E1121, H1174, and E1245
were substituted by alanine residues. The results show that
even the quadruple area 1 mutant is still capable of interacting
with RPGR, whereas only a very weak interaction is observed
for the triple mutant of area 2 (Figure 3A). Circular dichroism
spectroscopy measurements show that the far-UV spectra of
both mutant proteins are similar to the spectrum of the wild-
type (data not shown); hence, the lack of interaction of the area
2 mutant is not caused by improper folding of the protein.
Consequently, we conclude that contact area 2 represents the
biological relevant interface between RPGR and RID196 (Figures
2C–2E and 2G).
Thus, RID196 contacts RPGR in three regions: a central
one involving interaction between a b sheet of RID196 and
some side chains (e.g., E1245, E1121, and H1174) with the large
loop of RPGR containing R323, N333, and N336; a mainly hydro-
phobic interaction site with the RPGR loop containing F271,
F279, and F281; and a third one formed by the N-terminal pep-
tide of RID196.
To investigate this interaction in more detail, we prepared
several charge-reversal mutants and evaluated their binding
capacities by pull-downs (Figure 3B). In RID222, the E1245Kmu-
tation does not have an effect on RPGR binding. The E1121K
mutation weakens the interaction, whereas H1174D totally abol-
ishes binding. In RPGR, the D321K mutation does not affect the
interaction with RID222, whereas R323E is no longer capable of
binding to RID222. This indicates that H1174 and R323 are the
most important residues for stabilizing the RPGR-RID interac-
tion. The side chains of H1174 and R323 are orientated in a
parallel fashion toward each other (Figure 2D) and the distance
between them is about 3.6–3.8 A˚, which is optimal for the forma-
tion of like-charged stacked interaction pairs (Heyda et al., 2010).
LCA and RP Patient Mutations
A large number of RP patient mutations throughout the RCC1
domain of RPGR have been reported. Judging from the RPGR
crystal structure, some of these mutations are considered toCell Reports 8, 1–9, July 10, 2014 ª2014 The Authors 3
Figure 4. Influence of Patient Mutations and PDEd on the RPGR-
RPGRIP1 Interaction
(A and B) Patient mutations close to the RPGR-RID196 interfaces are shown
in green.
(C and D) Pull-downs of Strep-tagged RPGR and RID222 proteins.
(C) RPGR proteins containing a patient mutation (indicated in blue) added
to wild-type RID222.
(D) Wild-type RPGR added to RID222 or RID240 proteins (wild-type or
containing the patient mutation indicated in blue).
(E and F) Binding of RPGRIP1 and PDEd to RPGR.
(E) Superimposition of the RPGR-PDEd (PDB ID 4JHP) and RPGR-RID196
complexes using RPGR as template.
(F) Pull-down of RPGR and RID222 in the presence of increasing concentra-
tions of PDEd.
Figure 3. Mutational Analysis and Verification of the Solution
Interface
(A and B) Pull-downs of Strep-tagged RPGR and RID222 proteins. As a pos-
itive control, only RPGR was added to the beads. As a negative control and to
check for unspecific binding, wild-type and mutant RID222 proteins were
added to the beads in the absence of RPGR. Diagrams show which interface
residues were mutated. In the diagrams, salt bridges are indicated by black
lines, H bonds are shown as black dotted lines, and hydrophobic interactions
are shown as gray dotted lines. The stacked interaction between H1174 and
R323 is shown in red.
(A) Pull-downs with RPGR and RID222 proteins with alanine mutations in the
contact areas. The RID222 area 1 protein contains the mutations K1174A,
K1220A, K1221A, and E1222A. The RID222 area 2 protein comprises E1121A,
H1174A, and E1245A mutations. The Ala mutations are indicated in red in the
diagrams representing the interfaces.
(B) Pull-downs of RPGR and RID222 proteins containing opposite-charge
mutations (indicated in blue) in the interaction interface. Each charge reversal
mutation is shown in blue in the diagrams.destabilize the b-propeller domain (Wa¨tzlich et al., 2013). Some
of the mutations of surface-exposed residues might influence
the interaction with different cellular partners. However, these
mutations do not affect the interaction between RPGR and
PDEd (Wa¨tzlich et al., 2013). The patient mutations that seem
most likely to influence the RPGR-RID interaction are the
RPGR mutations G320R and H324E, given their proximity to
the interface (Figure 4A). The K29R and N345D disease-related
mutations in RPGR are located in the vicinity of the disordered
linker connecting the N-terminal peptide of the RID domain to
the start of the C2 domain at residue D1114 (Figure 4B). We
thus introduced the four patient mutations into RPGR and iso-
lated the proteins. The G320R mutation led to an insoluble
RPGR protein (it introduces a steric clash to the loop containing
F271), but the other mutations did not affect the solubility of the4 Cell Reports 8, 1–9, July 10, 2014 ª2014 The Authorsprotein. Pull-down experiments showed that none of these
mutations had any visible effect on binding the RID of RPGRIP1
(Figure 4C).
The RPGRIP1 mutation D1114G found in LCA has been
described to abolish the interaction with the RCC1 domain of
RPGR (Lu et al., 2005). Based on our crystal structure, this
seems highly unlikely, as residue D1114 is not localized near
the interface. Pull-downs confirmed that this mutation indeed
does not interrupt RPGR binding (Figures 4B and 4D).
PDEd and RPGRIP1 Competition
PDEd loaded with farnesylated RheB cargo can dock onto the
surface of RPGR to form a stable ternary complex (Wa¨tzlich
et al., 2013). An overlay of the RPGR-PDEd and RPGR-RID com-
plexes, however, shows that PDEd and RPGRIP1 bound to the
Figure 5. Comparison of the RPGRIP1 and RPGRIP1L Interaction
with RPGR
(A and B) Pull-down experiments with Strep-tagged RPGR and (A) RIDL pro-
teins of different lengths as indicated in Figure 1A, with RID222 for comparison
(last lane), and (B) RID222, in which the N-terminal binding peptide (V1101
IVPPM) is replaced by the concordant RIDL246 sequence (N1117FRLPG) and
vice versa.
(C) A preformed RPGR-RIDL279 complex is incubated with increasing
amounts of RID222. The last two lanes show binding of RPGR-R323E to
RIDL279 and His-RID222.
(D) A preformed RPGR-RIDL246 complex is incubated with increasing
amounts of RID222.surface of RPGR would clash with each other (although the
overlap is quite small), indicating that their binding is at least
partially exclusive. A ternary complex among RPGR, PDEd,
and RPGRIP1 in which the RIDwould contact both contact areas
of the RPGR b propeller seems sterically not feasible (Figure 4E).
However, since the interface areas on the top and side of the
propeller are of similar sizes, it is feasible that the PDEd-cargo
complex might weaken, but not interrupt, the RPGR-RPGRIP1
interaction. Biochemical experiments in which we titrated
increasing amounts of PDEd to a preformed RPGR-RID222 com-
plex support the notion that PDEd binding reduces the affinity of
the interaction between RPGR and RPGRIP1 (Figure 4F).
RPGRIP1 versus RPGRIP1L
RPGRIP1L is considered a close homolog of RPGRIP1 and has
the same domain architecture (Figure 1A). Previous yeast-two-
hybrid experiments described binding of the C-terminal domain
of RPGRIP1L to RPGR as well (Khanna et al., 2009). To investi-
gate the interaction between RPGR and RPGRIP1L, we created
constructs for the C-terminal domain of RPGRIP1L starting from
amino acids M1037, L1070, S1109, T1137 and P1145 (Fig-
ure 1A), producing RID-like (RIDL) domains of 279, 246, 207,
179, and 171 residues. Pull-downs with Strep-tagged RPGR
show that RIDL279 and RIDL246 bind to the RCC1 domain of
RPGR (Figure 5A). A comparison with the RID constructs of
RPGRIP1 and their interactions (Figure 1B) demonstrates that
the RIDL constructs need to be much longer (the interaction isalready very weak with RIDL246) and bind with apparently lower
efficiency (Figures 5A, 5C, and 5D).
The sequence alignment of the C-terminal domains of
RPGRIP1 and RPGRIP1L shows that residues E1121 and
E1245, which are part of the central region of the RPGR-
RPGRIP1 interface and form salt bridges to R323, are conserved
in RPGRIP1L (Figure S2). However, residue H1174 of RPGRIP1,
which seems essential for binding, is not conserved in
RPGRIP1L. It is replaced by Asn1202, which in principle could
also be involved in a similar type of H-bond donor and/or
acceptor interaction with RPGR residues D321 and N336.
The most significant difference in interface residues between
RPGRIP1 and RPGRIP1L is the N-terminal peptide D1097
SDDVIVPPM of RPGRIP1, which does not seem to have an
equivalent in RPGRIP1L. Although sequence homology is very
weak in this area, we considered the region (N1117FRLPG) in
RPGRIP1L as a potential analog of V1101IVPPM (Figure S2).
To get an idea of the importance of this small peptide, we re-
placed the sequence in RPGRIP1 by the respective RPGRIP1L
sequence and vice versa. Pull-downs show that RID222 with
NFRLPG no longer interacts with RPGR (Figure 5B). This is
consistent with the observed bindingmode of the peptide, where
V1101 and P1104 latch into two depressions of the RPGR sur-
face (Figure 2E). Mutation to larger residues (N and L in this
case) would be expected to disrupt binding. One might argue
that replacing the peptide in RIDL246 by the RID sequence
could lead to an increased interaction with RPGR. However,
pull-downs show that RIDL246-VIVPPM no longer interacts
with RPGR (Figure 5B).
To investigate the differences between the RID and RIDL pro-
teins in more detail, we performed competition experiments. We
formed RPGR-RIDL complexes by incubating 20 mM RPGR with
60 mMRIDL279 or RIDL246. Then, we added increasing amounts
of RID222 (0, 5, 20, 60, and 80 mM for RIDL279; and 0, 5, 20, and
60 mM for RIDL246). Although 60 mM RID222 is sufficient to
completely outcompete binding of RIDL246 to RPGR, 80 mM
RID222 is required in the case of RIDL279 (Figures 5C and 5D).
Hence, the longer N terminus of RIDL279 seems to stabilize
the complex. Given that the RPGR mutation R323E abolishes
RID222 binding, we investigated its effect on RIDL279 binding
as well. As can be seen in Figure 4C, the R323E mutation also
diminishes the RIDL279 binding, but the effect is not as pro-
nounced as with RID222. Consequently, it appears that the
RID and RIDL proteins bind the RPGR b propeller in a similar
fashion, but RID binding is much stronger.
Comparison between the RID of RPGRIP1 and Other C2
Domains
In general, the sequence similarity between C2 domains is rela-
tively low, which renders correct identification quite difficult.
However, by applying several computational methods and in-
depth sequence analysis, Zhang and Aravind (2012), were able
to recognize several distinct types of C2 domains in ciliary pro-
teins. They identified three different types of C2 domains in
both RPGRIP1 and RPGRIP1L. Furthermore, they predicted
the middle C2 domain (C2C) to be a classical protein kinase C
(PKC)-C2 domain and postulated that the other two C2 domains
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file of RID196 as input identified theC2 domain of the human pro-
tein Itchy, a E3 ubiquitin protein ligase homolog (PDB ID 2NQ3,
rmsd = 2.24 A˚ over 115 residues) as the closest structural match
(Figure S3A). Other close matches include the C2A domain of
rat otoferlin (PDB ID 3L9B [Helfmann et al., 2011], rmsd =
2.73 A˚ over 112 residues; Figure S3B) and the C2N domain of
RPGRIP1L (PDB ID 2YRB, rmsd = 2.60 A˚ over 118 residues;
Figure S3C).
The 3D structure of most C2 domains consists of an eight-
stranded b sandwich composed of two four-stranded, antipar-
allel b sheets. The presence of a small a helix between b6 and
b7 is highly conserved as well. Superposition of RID196 with
the C2 domains of Itchy, otoferlin, and RPGRIP1L shows that
they all possess a type II topology and the positions of the b
sheets are rather conserved (Figure S3). However, there are
big differences in the loop regions. In comparison with the other
C2 domains, the b3 strand of RID196 is unusually short (two
amino acids compared with four in the human protein Itchy
and in otoferlin). Instead, a flexible loop runs in the opposite
direction of the b2 strand. Another striking difference between
RID222 and the Dali homologs is the presence of two extra
a helices—a2 and a4—near a3, where the N and C termini of
the molecule come close to each other.
Initially, C2 domains were thought to act as Ca2+-dependent
membrane-binding domains. The Ca2+-binding pocket is usually
composed of three different loops localized at one side of the
molecule. Generally, multiple Ca2+ ions are coordinated by
interactions with Asp side chains as well as with the protein
backbone. Lipid binding can occur via these Ca2+-binding loops
and/or a basic patch in the concave side of the b sandwich,
called the b groove. Surface-exposed residues in the Ca2+-bind-
ing loops determine selectivity for membrane phospholipids
such as phosphatidic acid, phosphatidylserine, and phosphati-
dylinositol, whereas the b groove usually binds different phos-
phatidylinositol phosphates (PIPs).
Superposition of the crystal structures of RID196 and PKCa
complexed with Ca2+ ions (PDB ID 3GPE) shows that the Asp
residues that coordinate the three Ca2+ ions in PKCa are absent
in the RID of RPGRIP1, and only Glu1224 is in a roughly similar
position to Asp254 in PKCa. However, it cannot be excluded
that the side chains of Glu1222 and Glu1224 and some
carbonyl oxygen atoms might nevertheless form a Ca2+-binding
pocket at that position. To determine whether the RIDC2 domain
binds Ca2+, we performed isothermal titration calorimetry (ITC)
experiments, which confirmed that no Ca2+ is bound to the RID
of RPGRIP1 under the same conditions in which Ca2+ binding
to the C2A domain of synaptotagmin I is observed (Figure S4A).
The crystal structure of PKCa in complex with PI(4,5)P2 (PDB
ID 3GPE) reveals the interaction of the lipid with the surface-
exposed side chains of K197, K209, and K211 (Figure S4B). Su-
perposition of the structures of PKCa and the RID of RPGRIP1
shows a charge reversal at the positions of K197 and K211,
and a helical turn containing L1153 occupies the place of
K209. Hence, it seems highly unlikely that PIPs are bound in
the b groove of the RID of RPGRIP1. PIP strips in the presence
or absence of CaCl2 did not show any interaction between
His6-tagged RID222 or RID196 and different phosphoinositides
(data not shown). A very weak interaction with phosphatidic6 Cell Reports 8, 1–9, July 10, 2014 ª2014 The Authorsacid was observed both with and without CaCl2. Other C2
domains have been reported to interact with phosphatidic acid
in a Ca2+-independent manner as well. As an example, PKCε
presumably binds phosphatidic acid using residues from the
loop connecting the b1 and b2 strands and the loop between
the b5 and b6 strands (Ochoa et al., 2001).
The b groove of PKCa, the binding site of PI(4,5)P2, shows a
positively charged surface potential (Figure S4C). In contrast,
the RID of RPGRIP1 displays a highly negatively charged surface
potential at the same position, and the loop connecting b5
and b6 would also sterically hinder PIP binding (Figure S4D).
The NMR structure of the C2N domain of RPGRIP1L possesses
a neutral to negatively charged b groove (Figure S4E), while a
model of the RIDL based on the RID crystal structure suggests
that the RIDL possesses an acidic b groove as well. Hence,
PIP binding by the C2N and RIDL domains of RPGRIP1L is simi-
larly unlikely.
DISCUSSION
RPGRIP1 and Cargo Trafficking
We previously presented amodel in which PDEd loaded with far-
nesylated cargo binds to RPGR, and Arl3-GTP binding to that
ternary complex releases cargo from PDEd and dissociates the
RPGR-PDEd complex (Wa¨tzlich et al., 2013). Here, we show
that binding of RPGR to RPGRIP1 and PDEd is at least partially
exclusive. RPGRIP1 was previously shown to localize correctly
to the connecting cilium of photoreceptors in RPGR/ mice,
whereas RPGR failed to localize to the connecting cilium
in RPGRIP1/ knockout mice (Zhao et al., 2003). Hence,
RPGRIP1 seems to be the primary docking platform responsible
for recruiting RPGR. Although the mechanistic implications
are not entirely clear, our competition experiments suggest
that the binding of PDEd to RPGR causes weakening of the
RPGR-RPGRIP1 complex. Since binding of RPGRIP1 involves
two binding sites, only one of which interferes with PDEd, cargo
unloading of the PDEd-cargo complex might involve a dynamic
shift from a two-partite interaction mode to a one-partite mode
involving RPGR and RPGRIP1/RPGRIP1L.
RPGRIP1 versus RPGRIP1L
The expression of RPGRIP1 seems to be limited to the retina,
while RPGRIP1L is more ubiquitously expressed (Arts et al.,
2007; Mavlyutov et al., 2002). Mutations in RPGRIP1 always
lead to disorders that display a retinal phenotype, whereas mu-
tations in RPGRIP1L lead to ciliopathies with a much broader
spectrum of clinical phenotypes. RPGRIP1L has been shown
to be a part of multiple ciliary complexes (Arts et al., 2007;
Chih et al., 2012; Sang et al., 2011; Williams et al., 2011), which
might explain its involvement in a multitude of ciliopathies. The
fact that the C2C domains of both RPGRIP1 and RPGRIP1L
interact with NPHP4, and both RID and RIDL interact with
RPGR suggests that both proteins fulfill a similar function. Our
competition experiments indicate that the interaction between
RID and RPGR is stronger than the interaction between
RIDL and RPGR independently of the RIDL construct used.
This may indicate that the RPGR-RPGRIP1 interaction plays a
more important role in the retina than in other tissues. Very
speculatively, this might be related to the enormous trafficking
rate of proteins (mainly rhodopsin) through the connecting cilium
of photoreceptors (Williams, 2002).
Our pull-down experiments with RID constructs of different
lengths show that the C2 domain alone is not sufficient to bind
RPGR. RID173 and RID185 (starting from amino acids I1102
and D1114, respectively) do not show any interaction with
RPGR, which indicates the importance of the extra interaction
between the flexible N terminus of RID and the side of the
RPGR b propeller. The same seems to be true for RPGRIP1L.
Sequence alignments predict the actual C2 domain to start at
residue P1145 (Figure S2), but no interaction is observed
between RPGR and RIDL207, RIDL179, and RIDL171 (starting
from amino acids S1109, T1137, and P1145, respectively).
Also, the interaction of RIDL246 with RPGR is weaker than the
interaction of RIDL279, which contains a longer N terminus.
Since the N-terminal sequence cannot be exchanged between
RID and RIDL without losing binding to RPGR, we speculate
that the binding interface on the side of the propeller is totally
different between RPGRIP1 and RPGRIP1L and cannot be in-
ferred from sequence alignment and modeling.
Ciliary C2 Domains as Protein-Protein Interaction
Modules
Transition zone proteins are linked to a broad range of ciliopa-
thies with overlapping phenotypes and seem to form large com-
plexes that together form the ciliary gate. One of the identified
subcomplexes is composed of NPHP1, NPHP4, and RPGRIP1L
(also called NPHP8) (Sang et al., 2011). Remarkably, all of these
proteins are predicted to contain one or more C2 domains.
Another complex consists of the three B9 domain proteins
(MKS1,MKSR1, andMKSR2) that are involved inMeckel-Gruber
syndrome (MKS), a neonatal lethal ciliopathy. B9 domains are
ciliary C2 domains that are not expected to bind Ca2+ and are
present in nearly all ciliated organisms (Bialas et al., 2009; Zhang
and Aravind, 2010). Furthermore, the MKS-associated protein
CC2D2A (= MKS6) and the Joubert-linked protein AhiI are pre-
dicted to possess C2 domains as well (Sang et al., 2011; Zhang
and Aravind, 2012). Yeast-two-hybrid experiments have shown
that the C2C domains of both RPGRIP1 and RPGRIP1L interact
with NPHP4, and in vitro pull-downs further demonstrated that
the interaction between the C2C of RPGRIP1 and NPHP4 is
Ca2+ independent (Roepman et al., 2005). Possibly, some of
these C2 domains might serve to anchor the transition zone
complexes to the membrane via their interactions with phospho-
lipids. However, based on our findings presented here, wewould
argue that these C2 domains instead serve as protein-protein
interaction modules connecting the different transition zone
proteins. Here, we show that the RPGR-interacting domain of
RPGRIP1 is a C2 domain as well. Its convex surface constitutes
themain interaction site with residues of the connecting loops on
the top of the RPGR b propeller.
Although the phospholipid- and Ca2+-binding properties
of many C2 domains are well characterized, very little is known
about how C2 domains mediate protein-protein interactions.
One of the few C2 domains that have been shown to act as a
genuine protein-protein interaction module is the C2A domain
of Munc13-1, which binds to the zinc finger domain of RIM2a(Lu et al., 2006). However, the binding mode is totally different
from the one we observe in the RPGR-RPGRIP1 complex.
One of the closest structural homologs of the RID of RPGRIP1
is theC2A domain of otoferlin (Figure S3B). Otoferlin is amulti-C2
domain protein that plays a role in exocytosis in auditory hair
cells. Most of its C2 domains have been implicated in Ca2+
and phospholipid binding (Johnson and Chapman, 2010). In
contrast, the C2A domain does not bind Ca2+ or phospholipids
and does not possess a positively charged b groove for the
interaction with PIPs (Helfmann et al., 2011). The function of
the C2A domain has not been elucidated, but it might also serve
as a protein-protein interacting domain.
CC2D2A (= MKS6) is a transition zone protein with a domain
architecture similar to that found in RPGRIP1 and RPGRIP1L.
CC2D2A is predicted to consist of a coiled coil domain followed
by two C2 domains and a transglutaminase-like domain (Zhang
and Aravind, 2012). Given that CC2D2A has been reported to be
present in several transition zone complexes, its C2 domains
might serve to interact with other proteins as well. In
C. elegans, multiple genes encoding transition zone proteins
were disrupted alone and in combination with each other (Wil-
liams et al., 2011). Based on the ciliary anomalies observed in
these mutant worms, CC2D2A was grouped in a MKS module
together with MKS1, MKSR1, MKSR2, and MKS3. RPGRIP1L
(NPHP8) was suggested to link the MKS module to an NPHP
module composed of NPHP1 and NPHP4. Using tandem affinity
purification (TAP) andmass spectrometry, Chih et al. (2012) iden-
tified a B9 complex composed of CC2D2A, MKS1, MKSR1,
MKSR2, AhiI, TCTN1, TCTN2, KCTD10, TMEM17, and
TMEM231. The majority of these proteins contain C2 domains,
which makes it more likely that specialized C2 domains, such
as those identified in this study, serve as the major protein-pro-
tein interaction modules in transition zone complexes.
EXPERIMENTAL PROCEDURES
Constructs
StrepII-tagged RPGR (comprising amino acids 1–392) was cloned into the
pET28a vector. All RID and RIDL constructs were cloned into a pProEx
Htb vector containing an N-terminal His6-tag and tobacco etch virus (TEV)
cleavage site. Mutagenesis was performed with the QuikChange method
(Stratagene).
Protein Purification
StrepII-tagged RPGR was expressed in E. coli BL21(DE3), and His6-tagged
RID and RIDL proteins were expressed in E. coli BL21(DE3) codon plus RIL
cells. His6-tagged C2A of synaptotagmin I was expressed in Rosetta(DE3)
cells. Bacterial cells were grown in terrific broth medium containing the appro-
priate antibiotics at 25C. Cells were induced with 100 mM isopropyl b-D-1-thi-
ogalactopyranoside and grown overnight at 18C to allow protein production.
StrepII-tagged RPGRwas purified over a Streptactin column, followed by size-
exclusion chromatography. His6-tagged RID and RIDL proteins were purified
over a His-Trap or Talon column, followed by size-exclusion chromatography.
When necessary, the His6-tag was removed by TEV cleavage overnight at 4
C.
The final buffer for all proteins contained 50 mM Tris pH 8.0, 50 mM NaCl, 5%
glycerol, and 1 mM TCEP. The His6-tagged C2A domain of synaptotagmin I
was purified in exactly the same way as the RID and RIDL proteins.
Crystallization, X-Ray Structure Solution, and Refinement
To set up crystal screens, 450 mMStrepII-tagged RPGR and 675 mMuntagged
RID196 were mixed in a 1:1 ratio. The best-diffracting crystals were obtainedCell Reports 8, 1–9, July 10, 2014 ª2014 The Authors 7
via the hanging-drop vapor diffusion method in a condition containing 300 mM
MgCl2 and 18% PEG-3350. Crystals containing the complex of RPGR and
selenomethionine-substituted RID196 were obtained in the same condition.
Crystals were flash-frozen using the mother liquor containing 25% of glycerol
as cryoprotectant. Selenomethionine single-wavelength anomalous diffraction
(SeMet SAD) and native X-ray data were recorded at the Swiss Light Source
(Villigen, Switzerland) at beamline PXII. Data were processed using XDS
(Kabsch, 2010) in space group P212121 at a resolution of 1.83 A˚ for the SeMet
SAD data. Because the quality of the native crystals was worse, the SeMet
data were used for refinement and model building. The crystal structure
was solved combining phases obtained by molecular replacement using the
RCC1 domain of RPGR (PDB ID 4JHN) as template and by SAD from seleno-
methionine-incorporated RID196. These steps were carried out using AutoSol
(Terwilliger et al., 2009) as part of Phenix (Adams et al., 2010). This final model
was built with Coot (Emsley and Cowtan, 2004) and refined with Phenix and
Refmac to an Rwork of 16.2% and an Rfree of 19.6%. TLS (Winn et al., 2001)
was applied at the end of the refinement and lowered the Rfree by 1.5%. All
figures were prepared with CCP4mg.
Pull-Downs
For pull-downs, 150 mg RID or RIDL and 50 mg StrepII-tagged RPGR proteins
were added to Streptactin beads. After 1 hr incubation at 4C, the beads were
washed thrice with a buffer containing 50 mM Tris pH 8.0, 50 mM NaCl, 5%
glycerol, 0.01% Tween20 and 1 mM tris(2-carboxyethyl)phosphine (TCEP).
Finally, the beads were eluted with buffer containing 5 mM D-desthiobiotin
and the elutions were loaded onto an SDS-PAGE gel for analysis.
For the RID/PDEd competition experiments, 35 mMRID222 and 11.5 mMStre-
pII-taggedRPGRwere added toStreptactin beads. After a 1 hr incubation at 4C
andwashing of the beads, increasing amounts of PDEd (0mM,0.14mM,0.28mM,
0.42 mM, 0.56 mM, 2.8 mM, 14 mM, 28 mM, and 56 mM) were added to separate
samples. The mixtures were incubated for 2 hr at 4C and the beads were
then washed three times. The beads were eluted with buffer containing 5 mM
D-desthiobiotinand theelutionswere loadedontoanSDS-PAGEgel for analysis.
For the competition experiments with RID and RIDL proteins, 60 mM
RIDL279 or RIDL246 and 20 mMStrepII-tagged RPGRwere added to Streptac-
tin beads. After a 2 hr incubation at 4C and washing of the beads, increasing
amounts of His6-tagged RID222 were added (0 mM, 5 mM, 20 mM, and 60 mM in
case of RIDL246, and 0 mM, 5 mM, 20 mM, 60 mM, and 80 mM in the case of
RIDL279) to separate the samples. The mixtures were incubated for 1 hr at
4C. After washing, the beads were eluted with buffer containing 5 mMD-des-
thiobiotin. The elutions were loaded onto an SDS-PAGE gel for analysis.
ITC Measurements
ITCmeasurements were performed on a MicroCal ITC200machine (GE Health-
care). TheC2Adomainof synaptotagmin IandtheRID222proteinsweredialyzed
twice into fresh buffer (50 mM Tris pH 8.0, 50 mMNaCl, 5% glycerol, and 1 mM
TCEP). CaCl2 (5 mM, dissolved in the same buffer) was titrated to 80 mMprotein.
Twenty 2 ml injections were used for the C2A domain of synaptotagmin I, and
18 2 ml injections were titrated to RID222.Measurements were performed twice,
and RID222 proteins from two independently purified batches were used.
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